CoQ10 vs PQQ
Two mitochondrial-support supplements often stacked together — one with a positive heart-failure mortality trial, the other with a strong biogenesis mechanism and thinner human outcome data.
CoQ10
Coenzyme Q10, ubiquinone, ubiquinol
Q-SYMBIO showed a real reduction in cardiovascular mortality and hospitalization when added to standard heart-failure therapy — a hard outcome, not a surrogate. Migraine prevention data are real but more modest; statin-myopathy relief did not beat placebo in meta-analysis. The 'declines with age, so restore it' pitch aimed at healthy adults has no supporting outcome trial.
Full CoQ10 evidence reviewPQQ
Pyrroloquinoline quinone
A genuine mitochondrial-biogenesis signal in cell and animal models, with a small number of short human trials on cognition and inflammation markers — promising mechanism, thin human outcome data.
Full PQQ evidence reviewSide by side
| CoQ10 | PQQ | |
|---|---|---|
| Marketed for | Heart failure adjunct, statin-myopathy relief, migraine prevention, general anti-aging 'energy' | Mitochondrial biogenesis, cognitive and cardiovascular support |
| Evidence grade | Clinical data | Clinical data |
| Family | NAD⁺ & mitochondrial | NAD⁺ & mitochondrial |
| Key human source | Q-SYMBIO, JACC Heart Failure 2014 | Mitochondrial biogenesis mechanism, J Biol Chem 2010 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
CoQ10's Q-SYMBIO trial is the strongest human outcome data either compound has — a real reduction in cardiovascular mortality in heart-failure patients. PQQ's case is mechanistic: it genuinely stimulates mitochondrial biogenesis in cell and animal models, and the human trials that exist are small and short, testing cognition and inflammation markers rather than hard outcomes. They're frequently sold together on the theory that CoQ10 supports existing mitochondria while PQQ helps make new ones — a plausible combination story that has never itself been tested.
CoQ10 fits if
You want the compound with an actual positive human outcome trial behind it, particularly if heart failure or statin-related muscle symptoms are the concern.
PQQ fits if
You're drawn to the mitochondrial-biogenesis mechanism specifically and are comfortable with thinner, shorter human data.